Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Hologic, Inc. stock logo
HOLX
Hologic
$64.02
+0.3%
$62.31
$51.90
$84.67
$14.23B0.552.39 million shs1.52 million shs
HealthEquity, Inc. stock logo
HQY
HealthEquity
$100.12
+2.5%
$101.51
$65.01
$116.65
$8.45B0.49871,918 shs1.06 million shs
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$69.50
+0.3%
$71.80
$60.56
$82.49
$8.44B0.871.74 million shs1.35 million shs
Masimo Corporation stock logo
MASI
Masimo
$158.35
-0.7%
$162.14
$101.61
$194.88
$8.65B1.19633,988 shs491,420 shs
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Hologic, Inc. stock logo
HOLX
Hologic
+0.25%-4.23%-0.19%+11.22%-18.85%
HealthEquity, Inc. stock logo
HQY
HealthEquity
+2.51%+3.01%+0.11%+18.46%+27.30%
Henry Schein, Inc. stock logo
HSIC
Henry Schein
+0.26%-6.75%-0.94%+7.37%-2.42%
Masimo Corporation stock logo
MASI
Masimo
-0.69%-4.79%-0.61%+4.07%+45.32%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Hologic, Inc. stock logo
HOLX
Hologic
4.7178 of 5 stars
3.23.00.04.32.83.31.9
HealthEquity, Inc. stock logo
HQY
HealthEquity
3.1896 of 5 stars
3.51.00.00.02.92.51.9
Henry Schein, Inc. stock logo
HSIC
Henry Schein
4.2756 of 5 stars
3.23.00.03.42.01.71.9
Masimo Corporation stock logo
MASI
Masimo
4.0705 of 5 stars
2.43.00.04.22.62.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Hologic, Inc. stock logo
HOLX
Hologic
2.47
Hold$77.3320.80% Upside
HealthEquity, Inc. stock logo
HQY
HealthEquity
3.00
Buy$118.5518.40% Upside
Henry Schein, Inc. stock logo
HSIC
Henry Schein
2.36
Hold$78.3612.75% Upside
Masimo Corporation stock logo
MASI
Masimo
2.83
Moderate Buy$191.6021.00% Upside

Current Analyst Ratings Breakdown

Latest HOLX, HQY, HSIC, and MASI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/16/2025
Hologic, Inc. stock logo
HOLX
Hologic
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$65.00 ➝ $70.00
7/14/2025
Henry Schein, Inc. stock logo
HSIC
Henry Schein
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$75.00
7/14/2025
Masimo Corporation stock logo
MASI
Masimo
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
7/14/2025
Henry Schein, Inc. stock logo
HSIC
Henry Schein
Baird R W
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
7/14/2025
Henry Schein, Inc. stock logo
HSIC
Henry Schein
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Neutral$82.00 ➝ $72.00
7/9/2025
Hologic, Inc. stock logo
HOLX
Hologic
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$60.00 ➝ $80.00
7/9/2025
Henry Schein, Inc. stock logo
HSIC
Henry Schein
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$72.00 ➝ $78.00
7/8/2025
Hologic, Inc. stock logo
HOLX
Hologic
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$62.00 ➝ $68.00
7/8/2025
HealthEquity, Inc. stock logo
HQY
HealthEquity
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingStrong-Buy ➝ Strong-Buy$115.00 ➝ $120.00
6/5/2025
HealthEquity, Inc. stock logo
HQY
HealthEquity
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$112.00 ➝ $125.00
6/5/2025
HealthEquity, Inc. stock logo
HQY
HealthEquity
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$98.00 ➝ $115.00
(Data available from 7/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Hologic, Inc. stock logo
HOLX
Hologic
$4.03B3.54$5.51 per share11.61$22.09 per share2.90
HealthEquity, Inc. stock logo
HQY
HealthEquity
$1.20B7.22$4.37 per share22.91$24.40 per share4.10
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$12.67B0.67$7.35 per share9.46$32.33 per share2.15
Masimo Corporation stock logo
MASI
Masimo
$2.09B4.10$6.34 per share24.96$19.50 per share8.12
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Hologic, Inc. stock logo
HOLX
Hologic
$789.50M$2.3727.0113.862.3413.83%19.71%10.87%7/30/2025 (Estimated)
HealthEquity, Inc. stock logo
HQY
HealthEquity
$96.70M$1.3773.0835.251.519.80%11.01%6.77%9/2/2025 (Estimated)
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$390M$3.2021.7213.842.243.21%14.87%5.82%8/5/2025 (Estimated)
Masimo Corporation stock logo
MASI
Masimo
-$304.90M-$9.17N/A34.20N/A-25.06%22.56%10.00%8/5/2025 (Estimated)

Latest HOLX, HQY, HSIC, and MASI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2025Q2 2025
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$1.19N/AN/AN/A$3.22 billionN/A
8/5/2025Q2 2025
Masimo Corporation stock logo
MASI
Masimo
$1.23N/AN/AN/A$368.65 millionN/A
7/30/2025Q3 2025
Hologic, Inc. stock logo
HOLX
Hologic
$1.05N/AN/AN/A$1.01 billionN/A
6/3/2025Q1 2026
HealthEquity, Inc. stock logo
HQY
HealthEquity
$0.81$0.97+$0.16$0.61$322.25 million$330.80 million
5/6/2025Q1 2025
Masimo Corporation stock logo
MASI
Masimo
$1.24$1.36+$0.12-$3.12$367.79 million$372.00 million
5/5/2025Q1 2025
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$1.11$1.15+$0.04$0.88$3.24 billion$3.17 billion
5/1/2025Q2 2025
Hologic, Inc. stock logo
HOLX
Hologic
$1.02$1.03+$0.01-$0.08$1.00 billion$1.01 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Hologic, Inc. stock logo
HOLX
Hologic
N/AN/AN/AN/AN/A
HealthEquity, Inc. stock logo
HQY
HealthEquity
N/AN/AN/AN/AN/A
Henry Schein, Inc. stock logo
HSIC
Henry Schein
N/AN/AN/AN/AN/A
Masimo Corporation stock logo
MASI
Masimo
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Hologic, Inc. stock logo
HOLX
Hologic
0.54
3.24
2.52
HealthEquity, Inc. stock logo
HQY
HealthEquity
0.50
4.06
4.06
Henry Schein, Inc. stock logo
HSIC
Henry Schein
0.50
1.38
0.75
Masimo Corporation stock logo
MASI
Masimo
0.67
2.17
1.62

Institutional Ownership

CompanyInstitutional Ownership
Hologic, Inc. stock logo
HOLX
Hologic
94.73%
HealthEquity, Inc. stock logo
HQY
HealthEquity
99.55%
Henry Schein, Inc. stock logo
HSIC
Henry Schein
96.62%
Masimo Corporation stock logo
MASI
Masimo
85.96%

Insider Ownership

CompanyInsider Ownership
Hologic, Inc. stock logo
HOLX
Hologic
1.88%
HealthEquity, Inc. stock logo
HQY
HealthEquity
1.50%
Henry Schein, Inc. stock logo
HSIC
Henry Schein
1.08%
Masimo Corporation stock logo
MASI
Masimo
9.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Hologic, Inc. stock logo
HOLX
Hologic
7,063222.85 million218.66 millionOptionable
HealthEquity, Inc. stock logo
HQY
HealthEquity
3,12086.47 million85.18 millionOptionable
Henry Schein, Inc. stock logo
HSIC
Henry Schein
25,000121.72 million120.41 millionOptionable
Masimo Corporation stock logo
MASI
Masimo
5,60054.22 million48.96 millionOptionable

Recent News About These Companies

Former Masimo COO is joining BD

New MarketBeat Followers Over Time

Media Sentiment Over Time

Hologic stock logo

Hologic NASDAQ:HOLX

$64.02 +0.16 (+0.25%)
Closing price 07/17/2025 04:00 PM Eastern
Extended Trading
$63.75 -0.27 (-0.43%)
As of 07/17/2025 05:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and connectivity solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, the company offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

HealthEquity stock logo

HealthEquity NASDAQ:HQY

$100.12 +2.45 (+2.51%)
Closing price 07/17/2025 04:00 PM Eastern
Extended Trading
$99.61 -0.51 (-0.51%)
As of 07/17/2025 06:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.

Henry Schein stock logo

Henry Schein NASDAQ:HSIC

$69.50 +0.18 (+0.26%)
Closing price 07/17/2025 04:00 PM Eastern
Extended Trading
$69.39 -0.11 (-0.16%)
As of 07/17/2025 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Masimo stock logo

Masimo NASDAQ:MASI

$158.35 -1.10 (-0.69%)
Closing price 07/17/2025 04:00 PM Eastern
Extended Trading
$158.66 +0.31 (+0.20%)
As of 07/17/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.